Adherence to therapy and adverse drug reactions: Is there a link?

Expert Opinion on Drug Safety

Volumn 13, Issue SUPPL. 1, 2014, Pages

  Leporini, Christian ^a   De Sarro, Giovambattista ^a   Russo, Emilio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Adherence; Adverse drug reaction; Compliance; Pharmacovigilance

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; DIGOXIN; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADVERSE DRUG REACTION; CORRELATION ANALYSIS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ECONOMIC ASPECT; HEALTH BEHAVIOR; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HUMAN; PATIENT COMPLIANCE; POLYPHARMACY; REVIEW; SOCIOECONOMICS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; QUALITY OF LIFE;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; MEDICATION ADHERENCE; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACOVIGILANCE; QUALITY OF LIFE;

EID: 84907022517     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2014.947260     Document Type: Review

References (122)

1. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002;162:2269-76
2. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998;20:764-71
3. Hughes CM. Medication non-adherence in the elderly: how big is the problem Drugs Aging 2004;21:793-811
4. Murray MD, Morrow DG, Weiner M, et al. A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother 2004;2:36-43
5. Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. Johns Hopkins University Press, Baltimore, MD; 1979
6. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol 1993;72:68D-74D
7. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011;9:11-23.
8. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002;CD000011.
9. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004;42:200-9
10. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40:794-811
11. WHO. Adherence to long-term therapies: evidence for action. World Health Organization, Geneva; 2003. WHO recommendation for improving patients' adherence.
12. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26:331-42
13. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008;CD000011.
14. Chiatti C, Bustacchini S, Furneri G, et al. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. Drug Saf 2012;35(Suppl 1):73-87.
15. Reeve E, Wiese MD. Benefits of deprescribing on patients' adherence to medications. Int J Clin Pharm 2014;36:26-9
16. Laufs U, Rettig-Ewen V, Bohm M. Strategies to improve drug adherence. Eur Heart J 2011;32:264-8
17. Kaiser RM, Schmader KE, Pieper CF, et al. Therapeutic failure-related hospitalisations in the frail elderly. Drugs Aging 2006;23:579-86
18. Carow F, Rieger K, Walter-Sack I, et al. Objective assessment of nonadherence and unknown co-medication in hospitalized patients. Eur J Clin Pharmacol 2012;68:1191-9
19. Degli Esposti L, Saragoni S, Batacchi P, et al. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Clin Ther 2012;34:190-9
20. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73:691-705
21. Conn VS, Hafdahl AR, Cooper PS, et al. Interventions to improve medication adherence among older adults: metaanalysis of adherence outcomes among randomized controlled trials. Gerontologist 2009;49:447-62
22. Turner BJ, Hollenbeak C,Weiner MG, et al. Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf 2009;18:672-81
23. Sabatè E. WHO Adherence Meeting Report. World Health Organization, Geneva; 2001.
24. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278-85
25. Miller WR, Rollnick S. Motivational interviewing: Preparing people for change. 2nd edition. Guilford Press, New York; 2002
26. Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med 2012;28:287-300
27. Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 2010;25:284-90
28. Raebel MA, Carroll NM, Ellis JL, et al. Importance of including early nonadherence in estimations of medication adherence. Ann Pharmacother 2011;45:1053-60
29. Fischer MA, Choudhry NK, Brill G, et al. Trouble getting started: predictors of primary medication nonadherence. Am J Med 2011;124:1081.e9-22
30. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44-7
31. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-90; discussion 3
32. Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag 2005;1:189-99
33. Williams M. Patient education. Achieving patient compliance. Nurs Times 1993;89:50-2
34. Cramer JA, Mattson RH. Monitoring compliance with antiepileptic drug therapy. In: Cramer JA, Spilker B, editors. Patient compliance in medical practice and clinical trials. Raven Press, New York; 1991. p. 123-37
35. Spector SL, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol 1986;77:65-70
36. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;10:348-54
37. McHorney CA. The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin 2009;25:215-38
38. Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003) 2011;51:90-4
39. Culig J, Leppee M. From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol 2014;38:55-62.
40. Matsui D, Hermann C, Klein J, et al. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol 1994;34:944-9
41. Vitolins MZ, Rand CS, Rapp SR, et al. Measuring adherence to behavioral and medical interventions. Control Clin Trials 2000;21:188S-94S
42. Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs 2013;73:545-62
43. Mazzitello C, Esposito S, De Francesco AE, et al. Pharmacovigilance in Italy: an overview. J Pharmacol Pharmacother 2013;4:S20-S8
44. Palleria C, Leporini C, Chimirri S, et al. Limitations and obstacles of the spontaneous adverse drugs reactions reporting: two "challenging" case reports. J Pharmacol Pharmacother 2013;4:S66-72
45. Sultana J, Cutroneo P, Trifiro G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother 2013;4:S73-S7
46. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300
47. Jonville-Bera AP, Bera F, Autret-Leca E. Are incorrectly used drugs more frequently involved in adverse drug reactions A prospective study. Eur J Clin Pharmacol 2005;61:231-6
48. Trifiro G, Spina E. Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems. Curr Drug Metab 2011;12:611-20
49. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital A systematic review. Br J Clin Pharmacol 2007;63:136-47
50. Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007;147:755-65
51. Budnitz DS, Pollock DA, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-66
52. Cohen AL, Budnitz DS, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr 2008;152:416-21
53. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004;57:121-6
54. Capuano A, Irpino A, Gallo M, et al. Regional surveillance of emergencydepartment visits for outpatient adverse drug events. Eur J Clin Pharmacol 2009;65:721-8
55. Capuano A, Motola G, Russo F, et al. Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res 2004;50:631-6
56. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008;42:1017-25
57. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004;329:15-19
58. Miranda V, Fede A, Nobuo M, et al. Adverse drug reactions and drug interactions as causes of hospital admission in oncology. J Pain Symptom Manage 2011;42:342-53
59. Chan A, Soh D, Ko Y, et al. Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients. Support Care Cancer 2014;22(7):1875-81
60. Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital inpatients: a prospective analysis of 3695 patient-episodes. PLoS One 2009;4:e4439
61. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997;315:1096-9
62. Bustacchini S, Corsonello A, Onder G, et al. Pharmacoeconomics and aging. Drugs Aging 2009;26(Suppl 1):75-87
63. Ahmad A, Mast MR, Nijpels G, et al. Identification of drug-related problems of elderly patients discharged from hospital. Patient Prefer Adherence 2014;8:155-65
64. Farrell B, Szeto W, Shamji S. Drug-related problems in the frail elderly. Can Fam Physician 2011;57:168-9
65. Pasina L, Brucato AL, Falcone C, et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging 2014;31:283-9
66. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5:345-51
67. Opondo D, Eslami S, Visscher S, et al. Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One 2012;7:e43617
68. Bainbridge JL, Ruscin JM. Challenges of treatment adherence in older patients with Parkinson's disease. Drugs Aging 2009;26:145-55
69. Zakharov S, Tomas N, Pelclova D. Medication errors-an enduring problem for children and elderly patients. Ups J Med Sci 2012;117:309-17
70. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007;30:911-18
71. Kojima T, Akishita M, Kameyama Y, et al. High risk of adverse drug reactions in elderly patients taking six or more drugs: analysis of inpatient database. Geriatr Gerontol Int 2012;12:761-2
72. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-12
73. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-6
74. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997;277:307-11
75. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34
76. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16
77. Thomsen LA, Winterstein AG, Sondergaard B, et al. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007;41:1411-26
78. Tache SV, Sonnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011;45:977-89
79. American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
80. Chang CM, Liu PY, Yang YH, et al. Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients. Pharmacotherapy 2005;25:831-8
81. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005;22:767-77
82. Jano E, Aparasu RR. Healthcare outcomes associated with beers' criteria: a systematic review. Ann Pharmacother 2007;41:438-47
83. Stockl KM, Le L, Zhang S, Harada AS. Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag Care 2010;16:e1-10
84. Dimitrow MS, Airaksinen MS, Kivela SL, et al. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc 2011;59:1521-30
85. Lund BC, Steinman MA, Chrischilles EA, Kaboli PJ. Beers criteria as a proxy for inappropriate prescribing of other medications among older adults. Ann Pharmacother 2011;45:1363-70
86. Fick D, Semla T. Improving medication use in gerontological nursing: now is the time for interdisciplinary collaboration and translation. J Gerontol Nurs 2011;37:3-4
87. Morandi A, Vasilevskis EE, Pandharipande PP, et al. Inappropriate medications in elderly ICU survivors: where to intervene Arch Intern Med 2011;171:1032-4
88. Campbell NL, Boustani MA, Skopelja EN, et al. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother 2012;10:165-77
89. Gazmararian JA, Kripalani S, Miller MJ, et al. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med 2006;21:1215-21
90. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97
91. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 2007;298:61-9
92. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for costrelated medication nonadherence: a review of the literature. J Gen Intern Med 2007;22:864-71
93. Imaz I, Zegarra P, Gonzalez-Enriquez J, et al. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 2010;21:1943-51
94. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30
95. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med 1997;157:1921-9
96. Elliott WJ, Maddy R, Toto R, Bakris G. Hypertension in patients with diabetes. Overcoming barriers to effective control. Postgrad Med 2000;107:29-32; 5-6, 8
97. Bedell SE, Jabbour S, Goldberg R, et al. Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med 2000;160:2129-34
98. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003;25:2958-71
99. Balkrishnan R, Bhosle MJ, Camacho FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal cohort study. J Urol 2006;175:1067-71; discussion 71-2
100. Ownby RL, Hertzog C, Crocco E, Duara R. Factors related to medication adherence in memory disorder clinic patients. Aging Ment Health 2006;10:378-85
101. Schnipper JL, Gandhi TK, Wald JS, et al. Design and implementation of a web-based patient portal linked to an electronic health record designed to improve medication safety: the Patient Gateway medications module. Inform Prim Care 2008;16:147-55
102. Woller W, Kruse J, Winter P, et al. Cortisone image and emotional support by key figures in patients with bronchial asthma. An empirical study. Psychother Psychosom 1993;59:190-6
103. Muller C, Hagele R, Heinl KW. [Differentiation and modification of compliance with reference to topical corticoid medication in patients with bronchial asthma]. Pneumologie 1996;50:257-9
104. Wagner EH, Grothaus LC, Sandhu N, et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care 2001;24:695-700
105. Broadhead RS, Heckathorn DD, Altice FL, et al. Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med 2002;55:235-46
106. Magura S, Laudet AB, Mahmood D, et al. Adherence to medication regimens and participation in dual-focus self-help groups. Psychiatr Serv 2002;53:310-16
107. Kulcar Z. Self-help, mutual aid and chronic patients' clubs in Croatia, Yugoslavia: discussion paper. J R Soc Med 1991;84:288-91
108. Feuerstein M, Lieb-Juckstock V, Schnaus H, et al. Compliance-a joint effort of the patient and his doctor. Epilepsy Res Suppl 1988;1:51-6
109. Carter IR, Nash C, Ridgway A. On any Saturday-a practical model for diabetes education. J Natl Med Assoc 2002;94:67-72
110. Ockene IS, Hayman LL, Pasternak RC, et al. Task force #4-adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference. J Am Coll Cardiol 2002;40:630-40
111. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998;36:1138-61
112. Julius RJ, Novitsky MA Jr, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract 2009;15:34-44
113. Ogedegbe G, Chaplin W, Schoenthaler A, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens 2008;21:1137-43
114. Resnick B, Fick DM. 2012 Beers criteria update: how should practicing nurses use the criteria Geriatr Nurs 2012;33:253-5
115. Fick DM, Semla TP. 2012 American Geriatrics Society Beers Criteria: new year, new criteria, new perspective. J Am Geriatr Soc 2012;60:614-15
116. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310
117. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713-19
118. Indian Polycap S, Yusuf S, Pais P, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009;373:1341-51
119. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006;296:2563-71
120. Bates DW, Miller EB, Cullen DJ, et al. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med 1999;159:2553-60
121. Hume AL, Quilliam BJ, Goldman R, et al. Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms. BMJ Qual Saf 2011;20:875-84
122. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24(1):67-74